Sepsis Clinical Trial
Aims: to explore the value of TREM-1 (triggering receptor expressed on myeloid cells-1)
,PCT(Procalcitonin), as well as CPIS (clinical pulmonary infection score) in the diagnostic
and prognostic assessment of VAP (ventilator associated pneumonia); and to make a comparison
with WBC (white blood cells) and CRP (C-reactive protein) level as well as SOFA (Sequential
Organ Failure Assessment) Score Methods: There were 92 subjects of sepsis, who were either
receiving endotracheal intubation or had undergone tracheotomy and were exposed to
mechanical ventilation. The subjects were divided into the VAP group (32) and the Non-VAP
group (60), the criterion being the contraction of VAP 48 hours after ICU admission.
Etiological culture was conducted in BALF (bronchoalveolar lavage fluid). And sTREM-1
density was determined by examining serum sTREM-1, PCT, WBC, CRP and EVC (exhaled ventilator
condensate). Meanwhile, the CPIS and SOFA score were worked out. With a 28-day survival as
the demarcation line, the VAP group was further divided into the survivors group, who stayed
alive for 28 days or more , and the non-survivors group, who died within 28 days. The
sTREM-1 and PCT level were denoted as meridians (range interquartile), while the WBC and CRP
level as well as the CPIS and SOFA score, means±standard deviations (SD).
Results: Averagely, the patients would contract clinically-confirmed VAP 6.9 days after
admission, which was mainly traced to Gram-negative bacilli infection. On the very day of
diagnosis, compared with the Non-VAP group, the VAP group showed a higher level of serum
sTREM-1, PCT, WBC and CRP as well as CPIS and SOFA score(295.6pg/ml vs.143.5pg/ml,
P<0.001;4.5ng/ml vs. 1.4ng/ml,P=0.008;16.7×10∧9/L vs.10.9×10∧9/L, P<0.001;11.5mg/dl vs.
7.7mg/dl,P=0.012; 6.0vs. 1.9, P<0.001;10.0vs. 7.5, P=0.017), AUC (area under the receiver
operating characteristic curve)turned out as follows :sTREM-1: 0.73(95% CI 0.61-0.85);PCT :
0.70(95% CI 0.57-0.83);WBC: 0.73(95% CI 0.60-0.85).The CPIS score, which was proved by
logistic regression analysis as the sole risky factor to VAP, amounted to 0.96(95% CI
0.91-1.00). Combined prediction probability containing all the data was calculated in
accordance on the relative regression equation. sTREM-1+WBC+CPIS score proved to be most
reliable for diagnosis. AUC turned out as 0.98. With 0.277 as the cut-off point, sensitivity
measured 0.97, specificity, 0.9 and YDI, 0.87. There were only 5 VAP subjects whose sTREM-1
density could be detected in EVC. The VAP patients were divided into a survivors group
(n=15) and a non-survivors group (n=17) with a 28-day survival as the demarcation line. The
non-survivors group demonstrated a higher PCT level and higher CPIS & SOFA score than the
survivors. (3.0ng/ml vs. 15.3ng/ml,P=0.032;5.4vs. 6.6, P=0.03;8.1vs.11.7 P=0.049). AUC
worked out PCT 0.752(95% CI 0.547-0.956)and CPIS 0.764(95% CI 0.575-0.953). Calculations on
the regression equation showed the PCT+CPIS score was most reliable for prognostic
assessment. AUC turned out as 0.848. With 0.516 as the demarcation line, sensitivity
measured 0.867, specificity, 0.818 and YDI, 0.685.
conclusion: WBC + CPIS helps improve VAP diagnosis; PCT+CPIS may be used for VAP prognostic
assessment. Taking two items into consideration will be of guiding value in VAP treatment as
well as mortality rate reduction. The sTREM-1 level in EVC,however,may be devoid of value
for VAP diagnosis.
n/a
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT05095324 -
The Biomarker Prediction Model of Septic Risk in Infected Patients
|
||
Completed |
NCT02714595 -
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
|
Phase 3 | |
Completed |
NCT03644030 -
Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
|
||
Completed |
NCT02867267 -
The Efficacy and Safety of Ta1 for Sepsis
|
Phase 3 | |
Completed |
NCT04804306 -
Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
|
||
Recruiting |
NCT05578196 -
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
|
N/A | |
Terminated |
NCT04117568 -
The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
|
||
Completed |
NCT03550794 -
Thiamine as a Renal Protective Agent in Septic Shock
|
Phase 2 | |
Completed |
NCT04332861 -
Evaluation of Infection in Obstructing Urolithiasis
|
||
Completed |
NCT04227652 -
Control of Fever in Septic Patients
|
N/A | |
Enrolling by invitation |
NCT05052203 -
Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
|
||
Terminated |
NCT03335124 -
The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock
|
Phase 4 | |
Recruiting |
NCT04005001 -
Machine Learning Sepsis Alert Notification Using Clinical Data
|
Phase 2 | |
Completed |
NCT03258684 -
Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock
|
N/A | |
Recruiting |
NCT05217836 -
Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
|
||
Completed |
NCT05018546 -
Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery
|
N/A | |
Completed |
NCT03295825 -
Heparin Binding Protein in Early Sepsis Diagnosis
|
N/A | |
Not yet recruiting |
NCT06045130 -
PUFAs in Preterm Infants
|
||
Not yet recruiting |
NCT05361135 -
18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia
|
N/A | |
Not yet recruiting |
NCT05443854 -
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
|
Phase 3 |